Table 1.
Study | Cohort designation | No of subjects | Country | Men (%) | Age range (years) | Study follow-up (years) | Outcomes measured |
---|---|---|---|---|---|---|---|
Albert et al 199922 | Physicians’ Health Study | 21 537 | USA | 100 | 40–84 | 12 | CHD mortality |
Bazzano et al 200723 | China National Hypertension Survey Epidemiology Follow-up Study | 64 338 | China | 100 | ≥40 | 8 | Incident stroke and stroke mortality |
Bazzano et al 200924 | 64 597 | China | 100 | ≥40 | 8 | Incident CHD; CVD and CHD mortality | |
Berberian et al 199425 | Zoetermeer Cohort | 1620 | Netherlands | 46.9 | >20 | 10 | CVD mortality |
Berger et al 199926 | Physicians’ Health Study | 22 071 | USA | 100 | 40–84 | 12.2 | Incident stroke |
Blackwelder et al 198027 | Honolulu Heart Program | 7888 | USA | 100 | Not reported | 8 | CHD and stroke mortality |
Boffetta et al 199028 | American Cancer Society Prospective Study | 276 802 | USA | 100 | 40–59 | 12 | CHD mortality |
Burke et al 200729 | Western Australian Aboriginal cohort | 514 | Australia | 50.2 | 15–88 | 11.6 | Incident CHD |
Camargo et al 199730 | Physicians’ Health Study | 22 071 | USA | 100 | 40–84 | 11 | Incident CHD |
Chiuve et al 200831 | Nurses’ Health Study | 71 243 | USA | 0 | 34–59 | 20 | Incident stroke |
Health Professionals Follow-up Study | 43 685 | USA | 100 | 40–75 | 18 | Incident stroke | |
Colditz et al 198532 | Massachusetts cohort | 1184 | USA | 38 | ≥66 | 4.75 | CHD mortality |
Cullen et al 199333 | Brusselton, Western Australian cohort | 2171 | Australia | 50 | ≥40 | 23 | CHD and CVD mortality |
Deev et al 199834 | US-Russian Lipid Research Clinics Prevalence Study | 4011 | USA | 46.6 | 40–69 | 13 | CVD mortality |
4153 | Russia | 46.7 | 40–69 | 13 | |||
Diem et al 200335 | Multinational Study of Vascular Disease in Diabetes | 287 | Switzerland | 56.4 | ≥35 | 12.6 | CHD mortality |
Djousse et al 200236 | Framingham Study | 9171 | USA | 42.2 | ≥50 | 10 | Incident stroke |
Djousse et al 200937 | Women’s Health Study | 26 399 | USA | 0 | ≥45 | 12 | CVD mortality |
Doll et al 200538 | British Physician Cohort | 12 325 | UK | 100 | 48–78 | 23 | CHD mortality |
Donahue et al 198639 | Honolulu Heart Program | 8006 | USA | 100 | 45–69 | 12 | Incident stroke |
Ebbert et al 200540 | Iowa Women’s Health Study | 30 518 | USA | 0 | 55–69 | 14 | CHD mortality |
Ebrahim et al 200841 | Women’s Heart and Health Study | 2717 | UK | 0 | 60–79 | 4.7 | Incident CHD |
Caerphilly Study | 1291 | UK | 100 | 47–67 | 20 | ||
Elkind et al 200642 | Northern Manhattan Study | 3176 | USA | 37.2 | ≥40 | 5.9 | Incident stroke |
Friedman et al 198643 | Framingham Study | 4745 | USA | 44.4 | 30–59 | 24 | CHD mortality |
Fuchs et al 199544 | Nurses’ Health Study | 85 709 | USA | 0 | 34–59 | 12 | CVD mortality |
Fuchs et al 200445 | Atherosclerosis Risk in Communities Study | 14 506 | USA | 43.3 | 45–64 | 9.8 | Incident CHD |
Garfinkel et al 198846 | American Cancer Society Prospective Study | 581 321 | USA | 0 | >30 | 12 | CHD mortality |
Garg et al 199247 | National Health and Nutrition Examination Study | 3718 | USA | 0 | 45–74 | 13 | CHD mortality |
Gaziano et al 200048 | Physicians’ Health Study | 89 299 | USA | 100 | 40–84 | 5.5 | CVD and stroke mortality |
Gordon et al 198349 | Framingham Study | 4625 | USA | 43.8 | 29–62 | 22 | Incident CHD |
Gordon et al 198550 | Albany Study | 1755 | USA | 100 | 38–55 | 18 | Incident CHD |
Gronbaek et al 199551 | Copenhagen City Heart Study | 13 285 | Denmark | 45.5 | 30–79 | 12 | CVD mortality |
Gun et al 200652 | Employees of Australian Institute of Petroleum member companies | 16 547 | Australia | 100 | NR | 20 | CHD mortality |
Hammar et al 199753 | Swedish Twin Register | 1900 | Sweden | 67.4 | 30–74 | NR | Incident CHD |
Hansagi et al 199554 | Swedish Twin Register | 15 077 | Sweden | 47 | ≥42 | 20 | Stroke mortality |
Harriss et al 200755 | Melbourne Collaborative Cohort Study | 38 200 | Australia | 39.7 | 27–75 | 11.4 | CHD and CVD mortality |
Hart et al 200856 | Midspan Collaborative Cohort Study | 6000 | Scotland | 100 | 35–64 | 35 | CHD and stroke mortality |
Hein et al 199657 | Copenhagen Male Study | 2826 | Denmark | 100 | 53–74 | 6 | Incident CHD |
Ikehara et al 200958 | Japan Public Health Center-Based Prospective Study | 19 356 | Japan | 100 | 40–69 | 9.9 | Incident CHD and stroke |
Iso et al 199559 | Rural Japanese cohorts | 2890 | Japan | 100 | 40–69 | 10.5 | Incident CHD and stroke |
Jakovljevic et al 200460 | Institute for Chronic Diseases and Gerontology | 286 | Serbia and Montenegro | 50.7 | 30–60 | 20 | Stroke mortality |
Jamrozik et al 200061 | Perth Community Stroke Study | 931 | Australia | 48 | >18 | 4 | CVD mortality |
Jousilahti et al 200062 | Finnish Cohort | 14 874 | Finland | 48.2 | 25–64 | 12 | Incident stroke |
Kitamura et al 199863 | Japanese Male Employees | 8476 | Japan | 100 | 40–59 | 8.8 | Incident CHD |
Kittner et al 198364 | Puerto Rico Heart Health Program | 9150 | Puerto Rico | 100 | 35–79 | 12 | Incident CHD and CHD mortality |
Kivela et al 198965 | Two Finnish cohorts from the Seven Countries Study | 1112 | Finland | 100 | 55–74 | 10 | CVD mortality |
Kiyohara et al 199566 | Hisayama Study | 1621 | Japan | 43.6 | ≥40 | 26 | Incident stroke |
Klatsky et al 199067 | Kaiser Permanente Medical Care Program Cohort | 123 840 | USA | 40.5 | <30–>70 | 7 | CVD mortality |
Klatsky et al 199768 | 128 934 | USA | 44 | <30–>70 | NR | Incident CHD | |
Klatsky et al 200269 | 128 934 | USA | 44 | <30–>70 | 18 | Incident stroke | |
Knoops et al 200470 | Healthy Ageing: A Longitudinal Study in Europe | 2339 | 11 European countries | 64.4 | 70–90 | 10 | CHD and CVD mortality |
Kono et al 198671 | Japanese Male Physician Cohort | 5135 | Japan | 100 | NR | 19 | CHD, CVD and stroke mortality |
Leppala et al 199972 | Alpha-Tocopherol, Beta-Carotene Cancer Prevention cohort | 26 556 | Finland | 100 | 50–69 | 6.1 | Incident stroke |
Lin et al 200573 | Japan Collaborative Cohort Study for Evaluation of Cancer Risk | 110 792 | Japan | 41.9 | 40–79 | 11 | CVD mortality |
Manttari et al 199774 | Helsinki Heart Study | 1924 | Finland | 100 | 40–55 | 5 | Incident CHD |
Marques-Vidal et al 200475 | PRIME Study—France | 7352 | France | 100 | 50–59 | 5 | Incident CHD |
PRIME Study—Northern Ireland | 2398 | Ireland | 100 | 50–59 | 5 | ||
Maskarinec et al 199876 | Multiethnic cohort (Hawaii) | 27 678 | USA | 50.1 | >30 | NR | CHD and stroke mortality |
Mukamal et al 200377 | Health Professionals Follow-up Study | 38 077 | USA | 100 | 40–75 | 12 | Incident CHD and CHD mortality |
Mukamal et al 200578 | Cardiovascular Health Study | 4410 | USA | 36.1 | ≥65 | 9.2 | Incident stroke |
Mukamal et al 200679 | 4410 | USA | 38.7 | ≥65 | 9.2 | Incident CHD | |
Murray et al 200280 | Manitoba Health Cohort | 1154 | Canada | 50.2 | 18–64 | 8 | Incident CHD |
Murray et al 200581 | Lung Health Study | 3702 | Canada | 100 | 35–60 | 14 | Incident CHD |
Pedersen et al 200882 | Copenhagen City Heart Study | 11 914 | Denmark | 44.3 | ≥20 | 20 | CHD mortality |
Rehm et al 199783 | National Health and Nutrition Examination Study | 6788 | USA | 43.6 | 40–75 | 14.6 | Incident CHD and CHD mortality |
Renaud et al 199984 | Cohort from Centre de Medecine Preventive | 36 250 | France | 100 | 40–60 | 12–18 | CHD and CVD mortality |
Salonen et al 198385 | Two counties of eastern Finland | 4063 | Finland | 100 | 30–59 | 7 | Incident CHD |
Sankai et al 200086 | Six Japanese communities | 12 372 | Japan | 40.2 | 40–69 | 9.4 | Incident stroke |
Scherr et al 199287 | Established populations for Epidemiologic Studies of the Elderly | 6891 | USA | 36.9 | >65 | 5 | CVD mortality |
Shaper et al 198788 | British Regional Heart Study | 6103 | UK | 100 | 40–59 | 6.2 | Incident CHD |
Simons et al 199689 | Dubbo Cohort of New South Wales | 2805 | Australia | 44.1 | ≥60 | 6.4 | Incident CHD |
Solomon et al 200090 | Nurses’ Health Study | 121 700 | USA | 0 | 30–55 | NR | Incident CHD and CHD mortality |
Suh et al 199291 | Multiple Risk Factor Intervention Trial | 11 688 | USA | 100 | 35–57 | 3.8 | CHD mortality |
Suhonen et al 198792 | Social Insurance Institution’s Mobile Clinic Health Survey | 4532 | Finland | 100 | 40–64 | 5 | CHD mortality |
Thun et al 199793 | Cancer Prevention Study II | 489 626 | USA | 51.3 | 30–104 | 9 | CHD, CVD and stroke mortality |
Tolstrup et al 200694 | Danish Cohort | 53 500 | Denmark | 46.8 | 50–65 | 5.7 | Incident CHD |
Trevisan et al 200195 | Risk Factors and Life Expectancy Study | 8647 | Italy | 100 | 30–59 | 7 | CHD and CVD mortality |
Truelsen et al 199896 | Copenhagen City Heart Study | 13 329 | Denmark | 45.5 | 45–84 | 16 | Incident stroke |
Valmadrid et al 199997 | Wisconsin Epidemiologic Study of Diabetic Retinopathy | 983 | USA | 45.2 | NR | 12.3 | CHD mortality |
Waskiewicz et al 200498 | Pol-MONICA Programme | 5452 | Poland | 49.3 | 35–64 | NR | CVD mortality |
Wellmann et al 200499 | MONICA Augsburg Cohort | 2710 | Germany | 49.6 | 35–64 | 10 | Incident CHD |
Wilkins 2002100 | National Population Health Survey | 6014 | Canada | 43.8 | ≥40 | 4 | Incident CHD |
Woo et al 1990101 | Elderly Chinese Cohort | 427 | China | 40 | ≥60 | 2.5 | Incident stroke |
Xu et al 2007102 | Husbands from Shanghai Women’s Health Study | 64 515 | China | 100 | 30–89 | 4.6 | CHD and CVD mortality |
Yang et al 1999103 | South Bay Heart Watch Cohort | 1196 | USA | 89 | ≥45 | 3.4 | Incident CHD |
Yuan et al 1997104 | Four communities in Shanghai | 18 244 | China | 100 | 45–64 | 6.7 | CHD and stroke mortality |
Zhang et al 2004105 | Northern and southern Chinese populations | 12 352 | China | 100 | 35–59 | 15.2 | Incident stroke |
CHD=coronary heart disease. CVD=cardiovascular disease.